Wearable Focal Vibration Therapy on Upper Extremity Function of People With Multiple Sclerosis: A Pilot Study (NCT07376772)
Feasibility, Preliminary Efficacy, and User Perspective Usability of Wearable Focal Vibration Therapy on Upper Extremity Function of People With Multiple Sclerosis: A Pilot Study
🩺 Plain-English Summary (8th-Grade Level)
This pilot mixed-method study will evaluate the feasibility, preliminary efficacy, and user experience of a home-based wearable Focal Vibration Therapy (FVT) intervention for improving upper extremity (UEx) function in people with multiple sclerosis (MS). Fifteen adults with relapsing-remitting MS (PRMS) and self-reported UEx impairments will participate in a 4-week FVT program using MyovoltTM wearable FVT devices applied to arm muscles.
Who can join: Review the eligibility criteria below.
Location: Norman Fixel Institute for Neurological Diseases — Gainesville, Florida
Age range: 18 Years to 100 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (2 Sites)
- Norman Fixel Institute for Neurological Diseases — Gainesville, Florida
- University of Florida — Gainesville, Florida
📞 Contact the Study Coordinator
Phone: (352) 273-9934
Email: hongwu.wang@ufl.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Multiple Sclerosis (MS) - Relapsing-remitting
- A Study of Remibrutinib Using MR Imaging in Relapsing or Progressive MS — Cleveland, Ohio
- Exploration of Novel Imaging Biomarkers on OCT for Ublituximab Treatment Response in Multiple Sclerosis — Baltimore, Maryland
- Brain Imaging and Immune Changes During Remibrutinib Treatment in Multiple Sclerosis. — St Louis, Missouri
- Effects of Ublituximab on Motor Functions in Multiple Sclerosis — Atlanta, Georgia
Explore by condition: All Multiple Sclerosis (MS) - Relapsing-remitting clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.